FR2925338B1 - Peptide antimicrobien, medicament et composition pharmaceutique le contenant. - Google Patents

Peptide antimicrobien, medicament et composition pharmaceutique le contenant.

Info

Publication number
FR2925338B1
FR2925338B1 FR0709057A FR0709057A FR2925338B1 FR 2925338 B1 FR2925338 B1 FR 2925338B1 FR 0709057 A FR0709057 A FR 0709057A FR 0709057 A FR0709057 A FR 0709057A FR 2925338 B1 FR2925338 B1 FR 2925338B1
Authority
FR
France
Prior art keywords
pharmaceutical composition
antimicrobial peptide
composition containing
medicinal product
containing same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0709057A
Other languages
English (en)
Other versions
FR2925338A1 (fr
Inventor
Gaudin Celine Zatylnyj
Floc H Michele Baudy
Joel Henry
Matthieu Laurencin
Emilie Duval
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
De Caen Basse Normandie, University of
Centre National de la Recherche Scientifique CNRS
Universite de Caen Normandie
Serb SA
Original Assignee
De Caen Basse Normandie, University of
Centre National de la Recherche Scientifique CNRS
Universite de Caen Normandie
Serb SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by De Caen Basse Normandie, University of, Centre National de la Recherche Scientifique CNRS, Universite de Caen Normandie, Serb SA filed Critical De Caen Basse Normandie, University of
Priority to FR0709057A priority Critical patent/FR2925338B1/fr
Publication of FR2925338A1 publication Critical patent/FR2925338A1/fr
Application granted granted Critical
Publication of FR2925338B1 publication Critical patent/FR2925338B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention a pour objet un peptide antimicrobien dont la séquence en acides aminés est KKKKPLFGLFFGLF, ses dérivés et ses fragments présentant une activité antimicrobienne. L'invention concerne également un médicament et une composition pharmaceutique le comprenant.
FR0709057A 2007-12-21 2007-12-21 Peptide antimicrobien, medicament et composition pharmaceutique le contenant. Expired - Fee Related FR2925338B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0709057A FR2925338B1 (fr) 2007-12-21 2007-12-21 Peptide antimicrobien, medicament et composition pharmaceutique le contenant.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0709057A FR2925338B1 (fr) 2007-12-21 2007-12-21 Peptide antimicrobien, medicament et composition pharmaceutique le contenant.

Publications (2)

Publication Number Publication Date
FR2925338A1 FR2925338A1 (fr) 2009-06-26
FR2925338B1 true FR2925338B1 (fr) 2010-06-18

Family

ID=39431192

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0709057A Expired - Fee Related FR2925338B1 (fr) 2007-12-21 2007-12-21 Peptide antimicrobien, medicament et composition pharmaceutique le contenant.

Country Status (1)

Country Link
FR (1) FR2925338B1 (fr)

Also Published As

Publication number Publication date
FR2925338A1 (fr) 2009-06-26

Similar Documents

Publication Publication Date Title
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
CY1113299T1 (el) Πολυπεπτιδια απροτινινης για τη μεταφορα μιας ενωσης μεσα στον αιματοεγκεφαλικο φραγμο
DE60334773D1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
EA200501586A1 (ru) Фармацевтические продукты
IL172783A0 (en) Rasgap derived peptide for selectively killing cancer cells
NO330984B1 (no) Aminosyre-fenoksyestere, fremgangsmate for fremstilling av slike, mellomprodukter i synteseveien, farmasoytisk preparat omfattende slike samt anvendelse av slike for fremstilling av farmasoytisk preparat for behandling av sykdom
CY1112376T1 (el) Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2
EA200800360A1 (ru) Формуляции с высоким содержанием лекарства и дозированные формы
BR0210139A (pt) Composições farmacêuticas
EA200401526A1 (ru) Новые соединения и их применение
BR0314797A (pt) Derivados da pirimidineamida e o uso dos mesmos
ATE422356T1 (de) Pharmazeutische zubereitungen
CY1112637T1 (el) Παραγων για την προληψη και αγωγη των παθησεων του ηπατος περιεχοντας παραγωγο πυραζολοπυριμιδινης
DK1511489T3 (da) Nye farmaceutiske sammensætninger indeholdende flibanserin-polymorf A
EA200501821A1 (ru) Фармацевтическая комбинация, содержащая модафинил и другой лекарственный препарат
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
IT1299583B1 (it) Uso di proteine hmg-i per la preparazione di medicamenti ad attivita' citotossica
EA200701615A1 (ru) Новые лекарственные средства для лечения заболеваний дыхательных путей
HRP20070291T3 (en) Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis
MA30815B1 (fr) Medicament combine
ATE378063T1 (de) Pharmazeutische zusammensetzungen mit insulin und insulin-hexamer-liganden
FR2925338B1 (fr) Peptide antimicrobien, medicament et composition pharmaceutique le contenant.
ATE451340T1 (de) Deuterierte catecholaminderivate sowie diese verbindungen enthaltende arzneimittel
DK1268522T3 (da) LH-RH-antagonister samt fremstilling deraf og anvendelse deraf som lægemidler
BRPI0409793A (pt) 4-,6- ou 7-hidroxiindóis com grupos n-óxido e sua aplicação como produtos terapêuticos

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

ST Notification of lapse

Effective date: 20230808